Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ipsen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of idiopathic CD as determined by the enrolling investigator
If previously treated with a neurotoxin for CD, at least a 12-week interval must have elapsed between the last injection of Botulinum toxin A (BoNT-A) or Botulinum toxin B (BoNT-B) and the first dose of Dysport injected in this study
Patient is able to comply with the protocol (e.g., can visit the clinic as required and can complete questionnaires/telephone interviews)
Provision of written informed consent prior to enrollment
You may not be if
Contraindications to treatment with any BoNT-A or BoNT-B preparations
Based on Investigator opinion, patients in whom previous BoNT-A or BoNT-B therapy has failed to produce a clinical response or produced an intolerable adverse reaction
Anticipated concomitant treatment with BoNT for other than cervical dystonia
Secondary cervical dystonia
Clareo Health | DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia
